New Drug Approved by FDA for Opioid Dependence
The Carlat Addiction Treatment Report, Volume 1, Number 2, August 2013
https://www.thecarlatreport.com/newsletter-issue/catrv1n2/
Issue Links: Learning Objectives | Editorial Information
Topics: Addiction
The FDA approved the use of Zubsolv on July 3. The medication contains buprenorphine and naloxone and is manufactured by Swedish drug maker Orexo AB. It comes in a once-daily tablet that dissolves under the tongue.
You can't view details of this content, please login or buy subscription here